TY - JOUR
T1 - Balanced Fluid or 0.9% Saline in Children Treated for Septic Shock
AU - PRoMPT BOLUS Investigators of the PECARN, PERC, and PREDICT Networks
AU - Balamuth, Fran
AU - Weiss, Scott L.
AU - Long, Elliot
AU - Thompson, Graham C.
AU - Artis, Amanda S.
AU - Campos, Atzael B.
AU - Borland, Meredith L.
AU - Dalziel, Stuart R.
AU - Yock-Corrales, Adriana
AU - Singh, Ruchi
AU - Williams, Amanda
AU - Mickiewicz, Beata
AU - Hickey, Christopher P.
AU - Fitzgerald, Julie C.
AU - Laskin, Benjamin L.
AU - Hickey, Robert W.
AU - Eckerle, Michelle
AU - Alqurashi, Waleed
AU - Alpern, Elizabeth
AU - Ambroggio, Lilliam
AU - Badawy, Mohamed
AU - Baumer-Mouradian, Shannon
AU - Berthelot, Simon
AU - Clukies, Lindsay D.
AU - Craig, Simon
AU - Curtis, Sarah J.
AU - Davis, Adrienne L.
AU - Duffy, Susan
AU - Eisenberg, Matthew A.
AU - Emsley, Jason G.
AU - Festekjian, Ara
AU - George, Shane
AU - Green, Rebecca
AU - Gripp, Karen E.
AU - Jain, Priya G.
AU - Jani, Shefali
AU - Joubert, Gary I.
AU - Judge, Pavan
AU - Kam, April
AU - Kochar, Amit
AU - Koutroulis, Ioannis
AU - Kwok, Maria Y.
AU - Lane, Roni D.
AU - Lithgow, Anna
AU - Lloyd, Julia
AU - Mansour, Karim
AU - McManemy, Julie K.
AU - Morris, Claudia
AU - Phillips, Natalie
AU - Rao, Arjun
N1 - Copyright © 2026 Massachusetts Medical Society.
PY - 2026/9/3
Y1 - 2026/9/3
N2 - BACKGROUND: Whether treatment with balanced crystalloid fluid leads to better outcomes than 0.9% saline in children treated for septic shock is debated.METHODS: In this pragmatic clinical trial conducted at 47 emergency departments in five countries, patients (2 months to <18 years of age) with suspected septic shock and abnormal perfusion were randomly assigned to receive fluid resuscitation with either balanced fluid or 0.9% saline for up to 48 hours. The primary outcome was a major adverse kidney event (a composite of death, new renal-replacement therapy, or persistent kidney dysfunction) at 30 days after enrollment or hospital discharge, whichever occurred first.RESULTS: Of 9041 enrolled patients, 277 (6.1%) in the balanced-fluid group and 282 (6.2%) in the 0.9%-saline group withdrew from the trial, leaving 4235 and 4247 patients, respectively, for analysis. A primary-outcome event occurred in 137 patients (3.4%) in the balanced-fluid group and in 124 (3.0%) in the 0.9%-saline group (difference, 0.4 percentage points; 95% confidence interval [CI], -0.5 to 1.3; risk ratio, 1.10; 95% CI, 0.88 to 1.40; P = 0.85). The median number of hospital-free days during 28 days after enrollment was 23 (interquartile range, 19 to 25) in both groups. Hyperchloremia occurred in 868 patients (31.4%) in the balanced-fluid group and in 1383 (49.0%) in the 0.9%-saline group; hypernatremia in 52 (1.8%) and 89 (3.1%), respectively; and hyperlactatemia in 260 (19.8%) and 228 (16.7%). No differences in other safety outcomes or adverse events were seen.CONCLUSIONS: Among children treated for septic shock, no significant difference was seen in the incidence of death, new renal-replacement therapy, or persistent kidney dysfunction when fluid resuscitation was administered with balanced fluid as compared with 0.9% saline. (Funded by Eunice Kennedy Shriver National Institute of Child Health and Human Development and others; PRoMPT BOLUS ClinicalTrials.gov number, NCT04102371.).
AB - BACKGROUND: Whether treatment with balanced crystalloid fluid leads to better outcomes than 0.9% saline in children treated for septic shock is debated.METHODS: In this pragmatic clinical trial conducted at 47 emergency departments in five countries, patients (2 months to <18 years of age) with suspected septic shock and abnormal perfusion were randomly assigned to receive fluid resuscitation with either balanced fluid or 0.9% saline for up to 48 hours. The primary outcome was a major adverse kidney event (a composite of death, new renal-replacement therapy, or persistent kidney dysfunction) at 30 days after enrollment or hospital discharge, whichever occurred first.RESULTS: Of 9041 enrolled patients, 277 (6.1%) in the balanced-fluid group and 282 (6.2%) in the 0.9%-saline group withdrew from the trial, leaving 4235 and 4247 patients, respectively, for analysis. A primary-outcome event occurred in 137 patients (3.4%) in the balanced-fluid group and in 124 (3.0%) in the 0.9%-saline group (difference, 0.4 percentage points; 95% confidence interval [CI], -0.5 to 1.3; risk ratio, 1.10; 95% CI, 0.88 to 1.40; P = 0.85). The median number of hospital-free days during 28 days after enrollment was 23 (interquartile range, 19 to 25) in both groups. Hyperchloremia occurred in 868 patients (31.4%) in the balanced-fluid group and in 1383 (49.0%) in the 0.9%-saline group; hypernatremia in 52 (1.8%) and 89 (3.1%), respectively; and hyperlactatemia in 260 (19.8%) and 228 (16.7%). No differences in other safety outcomes or adverse events were seen.CONCLUSIONS: Among children treated for septic shock, no significant difference was seen in the incidence of death, new renal-replacement therapy, or persistent kidney dysfunction when fluid resuscitation was administered with balanced fluid as compared with 0.9% saline. (Funded by Eunice Kennedy Shriver National Institute of Child Health and Human Development and others; PRoMPT BOLUS ClinicalTrials.gov number, NCT04102371.).
KW - Acute Kidney Injury/diagnosis
KW - Adolescent
KW - Child
KW - Child, Preschool
KW - Creatinine/blood
KW - Crystalloid Solutions/administration & dosage
KW - Female
KW - Fluid Therapy/methods
KW - Humans
KW - Infant
KW - Isotonic Solutions/administration & dosage
KW - Male
KW - Renal Insufficiency, Chronic/diagnosis
KW - Renal Replacement Therapy/statistics & numerical data
KW - Saline Solution/administration & dosage
KW - Shock, Septic/therapy
KW - Treatment Outcome
UR - https://www.scopus.com/pages/publications/105049024105
U2 - 10.1056/NEJMoa2601969
DO - 10.1056/NEJMoa2601969
M3 - Article
C2 - 42028918
AN - SCOPUS:105049024105
SN - 0028-4793
VL - 395
SP - 870
EP - 881
JO - The New England journal of medicine
JF - The New England journal of medicine
IS - 9
ER -